The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Rabies Immune Globulin (Equine) Market Research Report 2024
Synopsis
Global Rabies Immune Globulin (Equine) market is projected to reach US$ 1526.7 million in 2029, increasing from US$ 1200 million in 2022, with the CAGR of 3.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Rabies Immune Globulin (Equine) market research.
Rabies Immune Globulin (Equine) is a medication used to prevent rabies infection in people who have been exposed to the virus. It is made from the blood of horses that have been immunized against rabies.
The development of Rabies Immune Globulin (Equine) involved the isolation and purification of antibodies from the blood of immunized horses. The process includes collecting blood from the horses, separating the plasma from the red blood cells, and purifying the antibodies using various techniques.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Rabies Immune Globulin (Equine) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Grifols
Serum China
Premium Serums
Intas
Aventis Pasteur India
Cadila Pharmaceuticals
Zydus Takeda Healthcare
Bharat Serums And Vaccines
GlaxoSmithKline GmbH
VINS Bioproducts
CSL Behring
Segment by Type
1500IU
1000IU
400IU
Others
Segment by Application
Clinic
Hospital
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Rabies Immune Globulin (Equine) report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Global Rabies Immune Globulin (Equine) market is projected to reach US$ 1526.7 million in 2029, increasing from US$ 1200 million in 2022, with the CAGR of 3.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Rabies Immune Globulin (Equine) market research.
Rabies Immune Globulin (Equine) is a medication used to prevent rabies infection in people who have been exposed to the virus. It is made from the blood of horses that have been immunized against rabies.
The development of Rabies Immune Globulin (Equine) involved the isolation and purification of antibodies from the blood of immunized horses. The process includes collecting blood from the horses, separating the plasma from the red blood cells, and purifying the antibodies using various techniques.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Rabies Immune Globulin (Equine) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Grifols
Serum China
Premium Serums
Intas
Aventis Pasteur India
Cadila Pharmaceuticals
Zydus Takeda Healthcare
Bharat Serums And Vaccines
GlaxoSmithKline GmbH
VINS Bioproducts
CSL Behring
Segment by Type
1500IU
1000IU
400IU
Others
Segment by Application
Clinic
Hospital
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Rabies Immune Globulin (Equine) report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Rabies Immune Globulin (Equine) Market Overview
1.1 Product Overview and Scope of Rabies Immune Globulin (Equine)
1.2 Rabies Immune Globulin (Equine) Segment by Type
1.2.1 Global Rabies Immune Globulin (Equine) Market Value Comparison by Type (2023-2029)
1.2.2 1500IU
1.2.3 1000IU
1.2.4 400IU
1.2.5 Others
1.3 Rabies Immune Globulin (Equine) Segment by Application
1.3.1 Global Rabies Immune Globulin (Equine) Market Value by Application: (2023-2029)
1.3.2 Clinic
1.3.3 Hospital
1.4 Global Rabies Immune Globulin (Equine) Market Size Estimates and Forecasts
1.4.1 Global Rabies Immune Globulin (Equine) Revenue 2018-2029
1.4.2 Global Rabies Immune Globulin (Equine) Sales 2018-2029
1.4.3 Global Rabies Immune Globulin (Equine) Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Rabies Immune Globulin (Equine) Market Competition by Manufacturers
2.1 Global Rabies Immune Globulin (Equine) Sales Market Share by Manufacturers (2018-2023)
2.2 Global Rabies Immune Globulin (Equine) Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Rabies Immune Globulin (Equine) Average Price by Manufacturers (2018-2023)
2.4 Global Rabies Immune Globulin (Equine) Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Rabies Immune Globulin (Equine), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rabies Immune Globulin (Equine), Product Type & Application
2.7 Rabies Immune Globulin (Equine) Market Competitive Situation and Trends
2.7.1 Rabies Immune Globulin (Equine) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Rabies Immune Globulin (Equine) Players Market Share by Revenue
2.7.3 Global Rabies Immune Globulin (Equine) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Rabies Immune Globulin (Equine) Retrospective Market Scenario by Region
3.1 Global Rabies Immune Globulin (Equine) Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Rabies Immune Globulin (Equine) Global Rabies Immune Globulin (Equine) Sales by Region: 2018-2029
3.2.1 Global Rabies Immune Globulin (Equine) Sales by Region: 2018-2023
3.2.2 Global Rabies Immune Globulin (Equine) Sales by Region: 2024-2029
3.3 Global Rabies Immune Globulin (Equine) Global Rabies Immune Globulin (Equine) Revenue by Region: 2018-2029
3.3.1 Global Rabies Immune Globulin (Equine) Revenue by Region: 2018-2023
3.3.2 Global Rabies Immune Globulin (Equine) Revenue by Region: 2024-2029
3.4 North America Rabies Immune Globulin (Equine) Market Facts & Figures by Country
3.4.1 North America Rabies Immune Globulin (Equine) Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Rabies Immune Globulin (Equine) Sales by Country (2018-2029)
3.4.3 North America Rabies Immune Globulin (Equine) Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Rabies Immune Globulin (Equine) Market Facts & Figures by Country
3.5.1 Europe Rabies Immune Globulin (Equine) Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Rabies Immune Globulin (Equine) Sales by Country (2018-2029)
3.5.3 Europe Rabies Immune Globulin (Equine) Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rabies Immune Globulin (Equine) Market Facts & Figures by Country
3.6.1 Asia Pacific Rabies Immune Globulin (Equine) Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Rabies Immune Globulin (Equine) Sales by Country (2018-2029)
3.6.3 Asia Pacific Rabies Immune Globulin (Equine) Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Rabies Immune Globulin (Equine) Market Facts & Figures by Country
3.7.1 Latin America Rabies Immune Globulin (Equine) Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Rabies Immune Globulin (Equine) Sales by Country (2018-2029)
3.7.3 Latin America Rabies Immune Globulin (Equine) Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Rabies Immune Globulin (Equine) Market Facts & Figures by Country
3.8.1 Middle East and Africa Rabies Immune Globulin (Equine) Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Rabies Immune Globulin (Equine) Sales by Country (2018-2029)
3.8.3 Middle East and Africa Rabies Immune Globulin (Equine) Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Rabies Immune Globulin (Equine) Sales by Type (2018-2029)
4.1.1 Global Rabies Immune Globulin (Equine) Sales by Type (2018-2023)
4.1.2 Global Rabies Immune Globulin (Equine) Sales by Type (2024-2029)
4.1.3 Global Rabies Immune Globulin (Equine) Sales Market Share by Type (2018-2029)
4.2 Global Rabies Immune Globulin (Equine) Revenue by Type (2018-2029)
4.2.1 Global Rabies Immune Globulin (Equine) Revenue by Type (2018-2023)
4.2.2 Global Rabies Immune Globulin (Equine) Revenue by Type (2024-2029)
4.2.3 Global Rabies Immune Globulin (Equine) Revenue Market Share by Type (2018-2029)
4.3 Global Rabies Immune Globulin (Equine) Price by Type (2018-2029)
5 Segment by Application
5.1 Global Rabies Immune Globulin (Equine) Sales by Application (2018-2029)
5.1.1 Global Rabies Immune Globulin (Equine) Sales by Application (2018-2023)
5.1.2 Global Rabies Immune Globulin (Equine) Sales by Application (2024-2029)
5.1.3 Global Rabies Immune Globulin (Equine) Sales Market Share by Application (2018-2029)
5.2 Global Rabies Immune Globulin (Equine) Revenue by Application (2018-2029)
5.2.1 Global Rabies Immune Globulin (Equine) Revenue by Application (2018-2023)
5.2.2 Global Rabies Immune Globulin (Equine) Revenue by Application (2024-2029)
5.2.3 Global Rabies Immune Globulin (Equine) Revenue Market Share by Application (2018-2029)
5.3 Global Rabies Immune Globulin (Equine) Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Grifols
6.1.1 Grifols Corporation Information
6.1.2 Grifols Description and Business Overview
6.1.3 Grifols Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Grifols Rabies Immune Globulin (Equine) Product Portfolio
6.1.5 Grifols Recent Developments/Updates
6.2 Serum China
6.2.1 Serum China Corporation Information
6.2.2 Serum China Description and Business Overview
6.2.3 Serum China Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Serum China Rabies Immune Globulin (Equine) Product Portfolio
6.2.5 Serum China Recent Developments/Updates
6.3 Premium Serums
6.3.1 Premium Serums Corporation Information
6.3.2 Premium Serums Description and Business Overview
6.3.3 Premium Serums Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Premium Serums Rabies Immune Globulin (Equine) Product Portfolio
6.3.5 Premium Serums Recent Developments/Updates
6.4 Intas
6.4.1 Intas Corporation Information
6.4.2 Intas Description and Business Overview
6.4.3 Intas Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Intas Rabies Immune Globulin (Equine) Product Portfolio
6.4.5 Intas Recent Developments/Updates
6.5 Aventis Pasteur India
6.5.1 Aventis Pasteur India Corporation Information
6.5.2 Aventis Pasteur India Description and Business Overview
6.5.3 Aventis Pasteur India Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Aventis Pasteur India Rabies Immune Globulin (Equine) Product Portfolio
6.5.5 Aventis Pasteur India Recent Developments/Updates
6.6 Cadila Pharmaceuticals
6.6.1 Cadila Pharmaceuticals Corporation Information
6.6.2 Cadila Pharmaceuticals Description and Business Overview
6.6.3 Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Cadila Pharmaceuticals Rabies Immune Globulin (Equine) Product Portfolio
6.6.5 Cadila Pharmaceuticals Recent Developments/Updates
6.7 Zydus Takeda Healthcare
6.6.1 Zydus Takeda Healthcare Corporation Information
6.6.2 Zydus Takeda Healthcare Description and Business Overview
6.6.3 Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Zydus Takeda Healthcare Rabies Immune Globulin (Equine) Product Portfolio
6.7.5 Zydus Takeda Healthcare Recent Developments/Updates
6.8 Bharat Serums And Vaccines
6.8.1 Bharat Serums And Vaccines Corporation Information
6.8.2 Bharat Serums And Vaccines Description and Business Overview
6.8.3 Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Bharat Serums And Vaccines Rabies Immune Globulin (Equine) Product Portfolio
6.8.5 Bharat Serums And Vaccines Recent Developments/Updates
6.9 GlaxoSmithKline GmbH
6.9.1 GlaxoSmithKline GmbH Corporation Information
6.9.2 GlaxoSmithKline GmbH Description and Business Overview
6.9.3 GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2018-2023)
6.9.4 GlaxoSmithKline GmbH Rabies Immune Globulin (Equine) Product Portfolio
6.9.5 GlaxoSmithKline GmbH Recent Developments/Updates
6.10 VINS Bioproducts
6.10.1 VINS Bioproducts Corporation Information
6.10.2 VINS Bioproducts Description and Business Overview
6.10.3 VINS Bioproducts Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2018-2023)
6.10.4 VINS Bioproducts Rabies Immune Globulin (Equine) Product Portfolio
6.10.5 VINS Bioproducts Recent Developments/Updates
6.11 CSL Behring
6.11.1 CSL Behring Corporation Information
6.11.2 CSL Behring Rabies Immune Globulin (Equine) Description and Business Overview
6.11.3 CSL Behring Rabies Immune Globulin (Equine) Sales, Revenue and Gross Margin (2018-2023)
6.11.4 CSL Behring Rabies Immune Globulin (Equine) Product Portfolio
6.11.5 CSL Behring Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rabies Immune Globulin (Equine) Industry Chain Analysis
7.2 Rabies Immune Globulin (Equine) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rabies Immune Globulin (Equine) Production Mode & Process
7.4 Rabies Immune Globulin (Equine) Sales and Marketing
7.4.1 Rabies Immune Globulin (Equine) Sales Channels
7.4.2 Rabies Immune Globulin (Equine) Distributors
7.5 Rabies Immune Globulin (Equine) Customers
8 Rabies Immune Globulin (Equine) Market Dynamics
8.1 Rabies Immune Globulin (Equine) Industry Trends
8.2 Rabies Immune Globulin (Equine) Market Drivers
8.3 Rabies Immune Globulin (Equine) Market Challenges
8.4 Rabies Immune Globulin (Equine) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
